Physician profile
Carolyn Eiland
NPI 1134389109
$564.17
in general payments reported to CMS, 2019-2025
15 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.99 · 2022: $57.86 · 2024: $109 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $469.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $146.57 | 2025 | Apretude |
| Lilly USA, LLC | $111.53 | 2022-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $49.46 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $37.84 | 2025 | |
| Sanofi Pasteur INC. | $27.37 | 2024 | |
| Novartis Pharmaceuticals Corporation | $24.34 | 2024 | |
| Paratek Pharmaceuticals, INC. | $23.87 | 2022 | |
| Novo Nordisk INC | $23.80 | 2021 | |
| Hologic Sales and Service, LLC | $23.41 | 2024 | Aptima |
| Gilead Sciences, INC. | $23.16 | 2025 | Yeztugo |
| Seqirus USA INC | $22.16 | 2025 | Fluad, Flucelvax |
| Amgen INC. | $14.86 | 2025 | Repatha, Otezla |
| Vbi Vaccine (Delaware) INC. | $13.89 | 2022 | |
| Amarin Pharma, INC. | $13.19 | 2021 | |
| Organon LLC | $8.72 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Eiland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.